162 related articles for article (PubMed ID: 10119488)
21. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
[TBL] [Abstract][Full Text] [Related]
22. Feds focus on medical devices.
Goldfarb B; Wolfberg D
JEMS; 1992 Jul; 17(7):35-8, 45-7. PubMed ID: 10120068
[No Abstract] [Full Text] [Related]
23. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
[TBL] [Abstract][Full Text] [Related]
24. Safety of reagents for infection testing: results of the market surveillance by the Federal Institute for Drugs and Medicinal Devices until end 2006.
Siekmeier R; Halbauer J; Mientus W; Wetzel D
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():629-43. PubMed ID: 19218690
[TBL] [Abstract][Full Text] [Related]
25. FDA marketing claims, and the practitioner.
Runner S
J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
[TBL] [Abstract][Full Text] [Related]
26. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
[TBL] [Abstract][Full Text] [Related]
27. Device tracking: user facility responsibilities.
Shepherd N
J Clin Eng; 1993; 18(5):441-52. PubMed ID: 10129809
[TBL] [Abstract][Full Text] [Related]
28. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
29. Medical device incident investigation.
Baretich MF
Biomed Sci Instrum; 2007; 43():302-5. PubMed ID: 17487098
[TBL] [Abstract][Full Text] [Related]
30. [Medical devices vigilance].
Crickx B
Ann Dermatol Venereol; 2008 Jan; 135(1 Pt 2):1S70-2. PubMed ID: 18442667
[TBL] [Abstract][Full Text] [Related]
31. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
Fed Regist; 1997 Dec; 62(246):67011-3. PubMed ID: 10179309
[TBL] [Abstract][Full Text] [Related]
32. Design and implementation of a portal for the medical equipment market: MEDICOM.
Palamas S; Kalivas D; Panou-Diamandi O; Zeelenberg C; van Nimwegen C
J Med Internet Res; 2001; 3(4):E32. PubMed ID: 11772547
[TBL] [Abstract][Full Text] [Related]
33. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
34. Medical devices; reports of corrections and removals--FDA. Final rule.
Fed Regist; 1997 May; 62(96):27183. PubMed ID: 10167533
[TBL] [Abstract][Full Text] [Related]
35. Brain-Computer Interface devices: risks and Canadian regulations.
Alpert S
Account Res; 2008; 15(2):63-86. PubMed ID: 18593098
[TBL] [Abstract][Full Text] [Related]
36. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
[TBL] [Abstract][Full Text] [Related]
37. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
38. Medical devices; reconditioners, rebuilders of medical devices; revocation of compliance policy guide; request for comments--FDA. Notice.
Fed Regist; 1998 Dec; 63(233):67076-8. PubMed ID: 10338883
[TBL] [Abstract][Full Text] [Related]
39. Medical devices vigilance: the European approach.
Freeman MF
Stud Health Technol Inform; 1996; 28():13-6. PubMed ID: 10172826
[TBL] [Abstract][Full Text] [Related]
40. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
